Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema. [electronic resource]
- The Journal of allergy and clinical immunology Oct 2010
- 821-827.e14 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
1097-6825
10.1016/j.jaci.2010.07.021 doi
Acute Disease Angioedemas, Hereditary--drug therapy Complement C1 Inhibitor Protein--administration & dosage Double-Blind Method Europe Female Humans Injections, Intravenous Male North America Pain Measurement Recombinant Proteins--administration & dosage Treatment Outcome